UniProt ID | TMUB1_HUMAN | |
---|---|---|
UniProt AC | Q9BVT8 | |
Protein Name | Transmembrane and ubiquitin-like domain-containing protein 1 | |
Gene Name | TMUB1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 246 | |
Subcellular Localization |
Membrane Multi-pass membrane protein . Cell junction, synapse, postsynaptic cell membrane . Recycling endosome . Cytoplasm . Nucleus . Nucleus, nucleolus . iHOPS: Cytoplasm . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Nucleus, |
|
Protein Description | Involved in sterol-regulated ubiquitination and degradation of HMG-CoA reductase HMGCR. [PubMed: 21343306 Involved in positive regulation of AMPA-selective glutamate receptor GRIA2 recycling to the cell surface (By similarity Acts as negative regulator of hepatocyte growth during regeneration (By similarity; iHOPS: May contribute to the regulation of translation during cell-cycle progression. May contribute to the regulation of cell proliferation (By similarity May be involved in centrosome assembly. Modulates stabilization and nucleolar localization of tumor suppressor CDKN2A and enhances association between CDKN2A and NPM1 (By similarity] | |
Protein Sequence | MTLIEGVGDEVTVLFSVLACLLVLALAWVSTHTAEGGDPLPQPSGTPTPSQPSAAMAATDSMRGEAPGAETPSLRHRGQAAQPEPSTGFTATPPAPDSPQEPLVLRLKFLNDSEQVARAWPHDTIGSLKRTQFPGREQQVRLIYQGQLLGDDTQTLGSLHLPPNCVLHCHVSTRVGPPNPPCPPGSEPGPSGLEIGSLLLPLLLLLLLLLWYCQIQYRPFFPLTATLGLAGFTLLLSLLAFAMYRP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
71 | Phosphorylation | GEAPGAETPSLRHRG CCCCCCCCCCCCCCC | 20.04 | 29255136 | |
73 | Phosphorylation | APGAETPSLRHRGQA CCCCCCCCCCCCCCC | 45.51 | 29255136 | |
77 | Methylation | ETPSLRHRGQAAQPE CCCCCCCCCCCCCCC | 32.27 | 115918669 | |
86 | Phosphorylation | QAAQPEPSTGFTATP CCCCCCCCCCCCCCC | 39.23 | 27174698 | |
87 | Phosphorylation | AAQPEPSTGFTATPP CCCCCCCCCCCCCCC | 47.21 | 27174698 | |
90 | O-linked_Glycosylation | PEPSTGFTATPPAPD CCCCCCCCCCCCCCC | 30.85 | OGP | |
90 | Phosphorylation | PEPSTGFTATPPAPD CCCCCCCCCCCCCCC | 30.85 | 25850435 | |
92 | Phosphorylation | PSTGFTATPPAPDSP CCCCCCCCCCCCCCC | 27.09 | 25159151 | |
92 | O-linked_Glycosylation | PSTGFTATPPAPDSP CCCCCCCCCCCCCCC | 27.09 | OGP | |
98 | Phosphorylation | ATPPAPDSPQEPLVL CCCCCCCCCCCCEEE | 27.68 | 25159151 | |
98 | O-linked_Glycosylation | ATPPAPDSPQEPLVL CCCCCCCCCCCCEEE | 27.68 | OGP | |
108 | Acetylation | EPLVLRLKFLNDSEQ CCEEEEEEECCCHHH | 41.18 | 25953088 | |
108 | Ubiquitination | EPLVLRLKFLNDSEQ CCEEEEEEECCCHHH | 41.18 | 21906983 | |
113 | Phosphorylation | RLKFLNDSEQVARAW EEEECCCHHHHHHHC | 28.93 | 21815630 | |
124 | Phosphorylation | ARAWPHDTIGSLKRT HHHCCCCHHHCCCCC | 24.97 | 23403867 | |
127 | Phosphorylation | WPHDTIGSLKRTQFP CCCCHHHCCCCCCCC | 27.20 | 25159151 | |
129 | Ubiquitination | HDTIGSLKRTQFPGR CCHHHCCCCCCCCCC | 55.91 | 21906983 | |
155 | O-linked_Glycosylation | LLGDDTQTLGSLHLP ECCCCCCCCCCCCCC | 34.87 | OGP | |
186 | Phosphorylation | NPPCPPGSEPGPSGL CCCCCCCCCCCCCCH | 46.52 | 25332170 | |
197 | Phosphorylation | PSGLEIGSLLLPLLL CCCHHHHHHHHHHHH | 22.85 | 25332170 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TMUB1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TMUB1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TMUB1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AMFR_HUMAN | AMFR | physical | 21343306 | |
ERLN2_HUMAN | ERLIN2 | physical | 21343306 | |
SYVN1_HUMAN | SYVN1 | physical | 21343306 | |
RN139_HUMAN | RNF139 | physical | 21343306 | |
A4_HUMAN | APP | physical | 21832049 | |
NPM_HUMAN | NPM1 | physical | 24240191 | |
RAGP1_HUMAN | RANGAP1 | physical | 24240191 | |
TBG1_HUMAN | TUBG1 | physical | 24240191 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-71; THR-92 AND SER-98,AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-92 AND SER-98, AND MASSSPECTROMETRY. |